Table 5.
Secondary analysis: PD-L1
PD-L1 density (mm2/mm2) | Rituximab Mean (95% CI) |
Controls Mean (95% CI) |
p |
---|---|---|---|
Tumor region | 0.059 (0.018, 0.099) | 0.083 (0.040, 0.127) | 0.36 |
Non-neoplastic region | 0.054 (0.004, 0.103) | 0.132 (0.056, 0.321) | 0.39 |
Within group difference | |||
Tumor − non-neoplastic | 0.005 (− 0.012, + 0.022) | − 0.049 (− 0.248, + 0.151) | 0.56 |
1. Density of tumor for subjects treated with rituximab
2. Density of adjacent normal tissue for subjects treated with rituximab
3. Use one sample t test to get the mean and 95% CI
4. p value is from two sample t-test
For two sample t-test, the Welch (or Satterthwaite) approximation to the degrees of freedom is used
Null hypothesis is no difference
5. (Tumor − normal) is calculated by: column K − column L